Effects of omega 3-PUFA on plasma fibrinogen levels in hypertriglyceridemic hemodialysis patients

Minerva Urologica e Nefrologica

Volumn 48, Issue 3, 1996, Pages 137-138

  Persichetti, S ^a   Maggi, S ^a   Ponzio, R ^a   Punzo, G ^a   Clemenzia, G ^b   Cottone, G ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b III Medical Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; OMEGA 3 FATTY ACID;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; HEMODIALYSIS; HUMAN; HYPERTRIGLYCERIDEMIA; ORAL DRUG ADMINISTRATION;

ARTERIOSCLEROSIS; DATA INTERPRETATION, STATISTICAL; FATTY ACIDS, OMEGA-3; FIBRINOGEN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; RENAL DIALYSIS;

EID: 0029811649     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Rolf N, Tenschert W et al. Results of a long term adminstration of Omega-3 fatty acids in HD patients with dyslipoproteinemia. Nephrol Dial Transplant 1990;5:797-801.
2. Hamazaki T, Nakazawa R et al. Effects of fish oil rich in eicosapentaenoic acid on serum lipid in hyperlipidemic hemodialysis patients. Kidney Int 1984;26:81-4.
3. Hostmark AT, Bjerkedal T et al. Fish oil and plasma fibrinogen. BMJ 1988;297:180-1.
4. Radack K, Deck C et al. Dietary supplementation with low dose fish oils lowers fibrinogen levels: a randomized double blind controlled study. Ann Int Med 1989;3(9):757-8.
5. Radack K, Deck C, Huster G. The comparative effects of N-3 and N-6 polyunsatured fatty acids on plasma fibrinogen levels: a controlled clinical trial in hypertriglyceridemic patients. J Am Coll Nutr 1990;9(4):352-7.